These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 19765188

  • 1. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis.
    Kawashima N, Tsuji D, Okuda T, Itoh K, Nakayama K.
    J Neurochem; 2009 Nov; 111(4):1031-41. PubMed ID: 19765188
    [Abstract] [Full Text] [Related]

  • 2. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D, Kuroki A, Ishibashi Y, Itakura T, Kuwahara J, Yamanaka S, Itoh K.
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL.
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice.
    Denny CA, Kasperzyk JL, Gorham KN, Bronson RT, Seyfried TN.
    J Neurosci Res; 2006 May 01; 83(6):1028-38. PubMed ID: 16521125
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.
    Tsuji D, Akeboshi H, Matsuoka K, Yasuoka H, Miyasaki E, Kasahara Y, Kawashima I, Chiba Y, Jigami Y, Taki T, Sakuraba H, Itoh K.
    Ann Neurol; 2011 Apr 01; 69(4):691-701. PubMed ID: 21520232
    [Abstract] [Full Text] [Related]

  • 12. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S, Miller JH, Brouxhon SM, Olschowka JA, Federoff HJ.
    Brain Res Mol Brain Res; 2005 Feb 18; 133(2):286-98. PubMed ID: 15710246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
    Seyrantepe V, Demir SA, Timur ZK, Von Gerichten J, Marsching C, Erdemli E, Oztas E, Takahashi K, Yamaguchi K, Ates N, Dönmez Demir B, Dalkara T, Erich K, Hopf C, Sandhoff R, Miyagi T.
    Exp Neurol; 2018 Jan 18; 299(Pt A):26-41. PubMed ID: 28974375
    [Abstract] [Full Text] [Related]

  • 17. Suppression of NK and CD8+ T cells reduces astrogliosis but accelerates cerebellar dysfunction and shortens life span in a mouse model of Sandhoff disease.
    White EJ, Trigatti BL, Igdoura SA.
    J Neuroimmunol; 2017 May 15; 306():55-67. PubMed ID: 28385189
    [Abstract] [Full Text] [Related]

  • 18. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A, Bourgoin C, Basso L, Emiliani C, Tancini B, Chigorno V, Li YT, Orlacchio A, Poenaru L, Sonnino S, Caillaud C.
    Neurobiol Dis; 2005 Nov 15; 20(2):583-93. PubMed ID: 15953731
    [Abstract] [Full Text] [Related]

  • 19. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA.
    Hum Mol Genet; 1997 Oct 15; 6(11):1879-85. PubMed ID: 9302266
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D, Higashine Y, Matsuoka K, Sakuraba H, Itoh K.
    Clin Chim Acta; 2007 Mar 15; 378(1-2):38-41. PubMed ID: 17196574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.